Literature DB >> 15277375

Islet allograft survival induced by costimulation blockade in NOD mice is controlled by allelic variants of Idd3.

Todd Pearson1, Peter Weiser, Thomas G Markees, David V Serreze, Linda S Wicker, Laurence B Peterson, Anne-Marie Cumisky, Leonard D Shultz, John P Mordes, Aldo A Rossini, Dale L Greiner.   

Abstract

NOD mice develop type 1 autoimmune diabetes and exhibit genetically dominant resistance to transplantation tolerance induction. These two phenotypes are genetically separable. Costimulation blockade fails to prolong skin allograft survival in (NOD x C57BL/6)F1 mice and in NOD-related strains made diabetes-resistant by congenic introduction of protective major histocompatibility complex (MHC) or non-MHC Idd region genes. Here, we tested the hypothesis that the genetic basis for the resistance of NOD mice to skin allograft tolerance also applies to islet allografts. Surprisingly, costimulation blockade induced permanent islet allograft survival in (NOD x C57BL/6)F1 mice but not in NOD mice. After costimulation blockade, islet allograft survival was prolonged in diabetes-resistant NOD.B6 Idd3 mice and shortened in diabetes-free C57BL/6 mice congenic for the NOD Idd3 variant. Islet allograft tolerance could not be induced in diabetes-resistant NOD.B10 Idd5 and NOD.B10 Idd9 mice. The data demonstrate that 1) NOD mice resist islet allograft tolerance induction; 2) unlike skin allografts, resistance to islet allograft tolerance is a genetically recessive trait; 3) an Idd3 region gene(s) is an important determinant of islet allograft tolerance induction; and 4) there may be overlap in the mechanism by which the Idd3 resistance locus improves self-tolerance and the induction of allotolerance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15277375     DOI: 10.2337/diabetes.53.8.1972

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  A multivalent vaccine for type 1 diabetes skews T cell subsets to Th2 phenotype in NOD mice.

Authors:  Ming S Lin; Hubert M Tse; Meghan M Delmastro; Suzanne Bertera; Caterina T Wong; Robert Lakomy; Jing He; Martha M Sklavos; Gina M Coudriet; Massimo Pietropaolo; Massimo M Trucco; Jon D Piganelli
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

2.  Administration of a negative vaccination induces hyporesponsiveness to islet allografts.

Authors:  M M Sklavos; G M Coudriet; M Delmastro; S Bertera; J T Coneybeer; J He; M Trucco; J D Piganelli
Journal:  Cell Transplant       Date:  2012-10-01       Impact factor: 4.064

3.  The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice.

Authors:  Calliope A Dendrou; Linda S Wicker
Journal:  J Clin Immunol       Date:  2008-09-09       Impact factor: 8.317

4.  Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource.

Authors:  Calliope A Dendrou; Vincent Plagnol; Erik Fung; Jennie H M Yang; Kate Downes; Jason D Cooper; Sarah Nutland; Gillian Coleman; Matthew Himsworth; Matthew Hardy; Oliver Burren; Barry Healy; Neil M Walker; Kerstin Koch; Willem H Ouwehand; John R Bradley; Nicholas J Wareham; John A Todd; Linda S Wicker
Journal:  Nat Genet       Date:  2009-08-23       Impact factor: 38.330

Review 5.  Commonality in the genetic control of Type 1 diabetes in humans and NOD mice: variants of genes in the IL-2 pathway are associated with autoimmune diabetes in both species.

Authors:  Dan B Rainbow; Laura Esposito; Sarah K Howlett; Kara M Hunter; John A Todd; Laurence B Peterson; Linda S Wicker
Journal:  Biochem Soc Trans       Date:  2008-06       Impact factor: 5.407

6.  CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice.

Authors:  Zhidan Xiang; Lian-Li Ma; Santhakumar Manicassamy; Balaji B Ganesh; Phillip Williams; Ravi Chari; Anita Chong; Deng-Ping Yin
Journal:  Transplantation       Date:  2008-04-27       Impact factor: 4.939

7.  Inotuzumab ozogamicin murine analog-mediated B-cell depletion reduces anti-islet allo- and autoimmune responses.

Authors:  Michele Carvello; Alessandra Petrelli; Andrea Vergani; Kang Mi Lee; Sara Tezza; Melissa Chin; Elena Orsenigo; Carlo Staudacher; Antonio Secchi; Kyri Dunussi-Joannopoulos; Mohamed H Sayegh; James F Markmann; Paolo Fiorina
Journal:  Diabetes       Date:  2011-11-10       Impact factor: 9.461

8.  Modifier loci condition autoimmunity provoked by Aire deficiency.

Authors:  Wenyu Jiang; Mark S Anderson; Roderick Bronson; Diane Mathis; Christophe Benoist
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307

Review 9.  Development of the Nonobese Diabetic Mouse and Contribution of Animal Models for Understanding Type 1 Diabetes.

Authors:  Yoko Mullen
Journal:  Pancreas       Date:  2017-04       Impact factor: 3.327

10.  Idd loci synergize to prolong islet allograft survival induced by costimulation blockade in NOD mice.

Authors:  Julie Mangada; Todd Pearson; Michael A Brehm; Linda S Wicker; Laurence B Peterson; Leonard D Shultz; David V Serreze; Aldo A Rossini; Dale L Greiner
Journal:  Diabetes       Date:  2008-11-04       Impact factor: 9.461

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.